Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 9Pheochromocytoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Paraganglioma 1Ovarian Neoplasms 1Endometrial Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Clear-cell metastatic renal cell carcinoma 1

Interventions

balstilimab 2tremelimumab 1spartalizumab 1pembrolizumab 1lenvatinib 1Standard of Care 1Pemetrexed 1Nivolumab 1Ipilimumab 1Carboplatin 1Axitinib 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Diabetes Mellitus, Insulin-Dependent, 12 × Axitinib × Clear all
NCT04522323 2025-07-25

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

MedImmune LLC

Phase 1 Active not recruiting
67 enrolled
Genitourinary

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡